9.3 Drug Design Targeting Viruses 547
9.4 Drug Design Targeting Bacteria 559
9.5 Drug Design Targeting Fungi 581
9.6 Drug Design Targeting Parasites 584
9.7 The Clinical–Molecular Interface: Pneumonia 591
9.8 The Clinical–Molecular Interface: Meningitis and Encephalitis 592
9.9 Drug Design of Therapies and Antidotes for Toxins 593
Selected References 596
Appendix: Drugs Arranged by Pharmacological Activity 601
Index 629
CONTENTS
xiii